JPWO2021173879A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021173879A5 JPWO2021173879A5 JP2022550908A JP2022550908A JPWO2021173879A5 JP WO2021173879 A5 JPWO2021173879 A5 JP WO2021173879A5 JP 2022550908 A JP2022550908 A JP 2022550908A JP 2022550908 A JP2022550908 A JP 2022550908A JP WO2021173879 A5 JPWO2021173879 A5 JP WO2021173879A5
- Authority
- JP
- Japan
- Prior art keywords
- binding
- scaffold
- cov
- sars
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062981453P | 2020-02-25 | 2020-02-25 | |
| US62/981,453 | 2020-02-25 | ||
| US202063002249P | 2020-03-30 | 2020-03-30 | |
| US63/002,249 | 2020-03-30 | ||
| US202062706225P | 2020-08-05 | 2020-08-05 | |
| US62/706,225 | 2020-08-05 | ||
| US202063091291P | 2020-10-13 | 2020-10-13 | |
| US63/091,291 | 2020-10-13 | ||
| PCT/US2021/019739 WO2021173879A1 (en) | 2020-02-25 | 2021-02-25 | Identification of biomimetic viral peptides and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023514452A JP2023514452A (ja) | 2023-04-05 |
| JP2023514452A5 JP2023514452A5 (https=) | 2024-03-05 |
| JPWO2021173879A5 true JPWO2021173879A5 (https=) | 2024-03-05 |
Family
ID=77492020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550908A Withdrawn JP2023514452A (ja) | 2020-02-25 | 2021-02-25 | 生体模倣ウイルスペプチドの特定及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230242592A1 (https=) |
| EP (1) | EP4110366A4 (https=) |
| JP (1) | JP2023514452A (https=) |
| KR (1) | KR20220158723A (https=) |
| CN (1) | CN115461068A (https=) |
| AU (1) | AU2021227918A1 (https=) |
| CA (1) | CA3172878A1 (https=) |
| IL (1) | IL295863A (https=) |
| WO (1) | WO2021173879A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20220552A (es) | 2020-04-02 | 2023-01-17 | Regeneron Pharma | Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno |
| US20230218742A1 (en) * | 2020-05-22 | 2023-07-13 | Riken | Multiple antigenic peptide against coronavirus and immunostimulating composition containing the same |
| CA3181026A1 (en) | 2020-06-03 | 2021-12-09 | Samit GANGULY | Methods for treating or preventing sars-cov-2 infections and covid-19 with anti-sars-cov-2 spike glycoprotein antibodies |
| IL310012A (en) | 2021-07-14 | 2024-03-01 | Regeneron Pharma | Antibodies against SARS-COV-2 spike glycoprotein and antigen-binding fragments |
| WO2023044494A2 (en) | 2021-09-17 | 2023-03-23 | Kotlyar David | Oral vaccine via dental bacteria and emitted peptides to prevent covid-19 infection |
| IT202200025416A1 (it) * | 2022-12-13 | 2024-06-13 | Univ Pisa | Biosensore per la rilevazione di particelle virali |
| CN117153245B (zh) * | 2023-10-18 | 2024-03-19 | 无锡市疾病预防控制中心 | 预测新型冠状病毒S蛋白RBD区域与hACE2受体相互作用的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017046801A1 (en) * | 2015-09-17 | 2017-03-23 | Ramot At Tel-Aviv University Ltd. | Coronaviruses epitope-based vaccines |
| CN110582301A (zh) * | 2016-12-14 | 2019-12-17 | 利甘达尔股份有限公司 | 用于核酸和蛋白质有效负载递送的方法和组合物 |
| US11365239B2 (en) * | 2020-03-20 | 2022-06-21 | Tsb Therapeutics (Beijing) Co., Ltd. | Anti-SARS-COV-2 antibodies and uses thereof |
-
2021
- 2021-02-25 IL IL295863A patent/IL295863A/en unknown
- 2021-02-25 KR KR1020227033145A patent/KR20220158723A/ko active Pending
- 2021-02-25 AU AU2021227918A patent/AU2021227918A1/en active Pending
- 2021-02-25 EP EP21760562.5A patent/EP4110366A4/en active Pending
- 2021-02-25 CN CN202180031498.6A patent/CN115461068A/zh active Pending
- 2021-02-25 JP JP2022550908A patent/JP2023514452A/ja not_active Withdrawn
- 2021-02-25 CA CA3172878A patent/CA3172878A1/en active Pending
- 2021-02-25 WO PCT/US2021/019739 patent/WO2021173879A1/en not_active Ceased
-
2022
- 2022-08-24 US US17/822,099 patent/US20230242592A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019203891B2 (en) | Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist | |
| JP6345216B2 (ja) | オキシントモジュリンと免疫グロブリン断片とを含む結合体及びその用途 | |
| JP6290193B2 (ja) | ペグ化ｏｘｍ変異体 | |
| TWI755579B (zh) | 新穎胰島素類似物及其用途 | |
| JP7761557B2 (ja) | グルカゴン、及びｇｌｐ－１受容体及びｇｉｐ受容体二重アゴニストを含む組成物及びその治療学的使用 | |
| US8716221B2 (en) | Modified exendins and uses thereof | |
| AU2019288471A1 (en) | Novel interleukin-15 (1L-15) fusion proteins and uses thereof | |
| AU2013250711A1 (en) | Long-acting oxyntomodulin variants and methods of producing same | |
| JP2016512213A5 (https=) | ||
| JP2011518179A5 (https=) | ||
| CN105229025B (zh) | 位点特异性胰岛素缀合物 | |
| CN113453703A (zh) | 包括胰岛素和对胰高血糖素和glp-1和gip受体均具有活性的三重激动剂的药物组合物 | |
| JP2024178193A (ja) | インスリン及びグルカゴンを含む薬学組成物 | |
| JPWO2021173879A5 (https=) | ||
| JP7650074B2 (ja) | 眼疾患を治療するための組成物及び方法 | |
| KR20180014754A (ko) | 페길화된 옥신토모둘린 변이체 | |
| NZ537634A (en) | The use of an immunogenic conjugate comprising at least one VEGF peptide moiety coupled to a carrier for use in combating tumours | |
| EP1001978B1 (en) | Angiotensin derivatives | |
| BR112019026336A2 (pt) | forma de sal de cloridrato de um peptídeo análogo da porção c-terminal de c5a e o uso da mesma, composição, método para induzir uma resposta imune contra uma infecção ou câncer, kit e composto para aumentar uma resposta imune para um agente imunogênico | |
| US20260028397A1 (en) | Methods of treating ankylosing spondylitis | |
| JP2023535382A (ja) | 三重作用性持続型結合体又は三重作用剤を含む組合せ物の治療学的用途 | |
| EP4504235A1 (en) | Methods of treating of hidradenitis suppurativa | |
| US7378489B1 (en) | Angiotensin derivatives | |
| BR112018013525B1 (pt) | Conjugado de longa atuação de agonista de receptor de glucagon/glp-1/gip triplo e composição farmacêutica | |
| JPWO2021140209A5 (https=) |